Loading…

Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease

Alzheimer disease (AD) is a progressive, degenerative and irreversible neurological disorder with few therapies available. In search for new potential targets, increasing evidence suggests a role for the endocannabinoid system (ECS) in the regulation of neurodegenerative processes. We have studied t...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2012-06, Vol.7 (6), p.e39186-e39186
Main Authors: D'Addario, Claudio, Di Francesco, Andrea, Arosio, Beatrice, Gussago, Cristina, Dell'Osso, Bernardo, Bari, Monica, Galimberti, Daniela, Scarpini, Elio, Altamura, A Carlo, Mari, Daniela, Maccarrone, Mauro
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Alzheimer disease (AD) is a progressive, degenerative and irreversible neurological disorder with few therapies available. In search for new potential targets, increasing evidence suggests a role for the endocannabinoid system (ECS) in the regulation of neurodegenerative processes. We have studied the gene expression status and the epigenetic regulation of ECS components in peripheral blood mononuclear cells (PBMCs) of subjects with late-onset AD (LOAD) and age-matched controls (CT). We found an increase in fatty acid amide hydrolase (faah) gene expression in LOAD subjects (2.30 ± 0.48) when compared to CT (1.00 ± 0.14; *p
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0039186